Evidence map›Paper›PMID 33251292›Full record

ArticleGE Portuguese journal of gastroenterology2020

Fibrolamellar Carcinoma: A Multimodal Approach.

João Vasco Barreira, Nádia Silva, Anuraj Parmanande, Manuel Rocha, João S Coelho, Hugo Pinto Marques, Ricardo da Luz

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in GE Portuguese journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

João Vasco BarreiraMedical Oncology Department, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Nádia SilvaGeneral Surgery Department, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Anuraj ParmanandeMedical Oncology Department, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Manuel RochaGastroenterology Department, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
João S CoelhoGeneral Surgery Department, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Hugo Pinto MarquesGeneral Surgery Department, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Ricardo da LuzMedical Oncology Department, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Unidade Local de Saúde de São José · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrolamellar carcinoma is a rare variant of hepatocellular carcinoma not associated with cirrhosis or viral hepatitis. Serum alpha-fetoprotein levels are usually normal; the histology is of a well-differentiated tumor, and the staging is the same as for hepatocellular carcinoma. We describe the case of a female patient in her 4th decade of life with a diagnosis of fibrolamellar hepatocellular carcinoma with a multimodal approach. The rare incidence of this cancer and its unusual clinical presentation justifies reporting this case and highlights the importance of multidisciplinary teams in the treatment of cancer patients.

Indexed as

Fibrolamellar carcinomaOncologyRare tumors

Identifiers

PMID33251292
PMCPMC7670382
OpenAlexW3016990160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.